PMID: 2106548Jan 1, 1990Paper

Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV)

Journal of Hepatology
U HopfF Deinhardt

Abstract

The natural course of chronic hepatitis non-A, non-B (HNANB) was documented for 3-20 yr (mean 8 yr) in 86 patients, who attended our special ambulance between 1981 and 1988. Sixty five of the 86 patients (75%) were positive for circulating antibodies against hepatitis C virus (HCV) (anti-HCV). Twenty four patients had chronic posttransfusion (PT)-HNANB (18 anti-HCV-positive; 75%), and 62 patients had sporadic (S)-HNANB (47 anti-HCV-positive; 75%). Twenty nine per cent of patients with chronic PT-HNANB had sustained normalization of aminotransferases after a period up to 5 yr, 55% demonstrated chronic persistent hepatitis (CPH) and 16% progressed to chronic active hepatitis (CAH) with transition to cirrhosis. In the group with chronic S-HNANB, 2% of patients showed remission, 43% had stable CPH and 55% progressed to CAH or cirrhosis. However, development of cirrhotic complications required many years. Transition from CAH to CPH or remission was not observed. The results indicate that 75% of both patients groups with chronic PT- and S-HNANB are infected with the same agent, of which antibodies are detected by the new anti-HCV assay. There was no statistical association between the severity of the disease and the presence of anti-...Continue Reading

References

Jan 1, 1979·Digestion·G HessK H Meyer zum Büschenfelde
Mar 11, 1976·The New England Journal of Medicine·U HopfW Arnold
Mar 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H ShiraishiR H Purcell
May 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E WalterW Gerok
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D DiMaioT Maniatis
May 23, 1980·Deutsche medizinische Wochenschrift·P A BergB Flehmig

❮ Previous
Next ❯

Citations

Oct 1, 1992·Digestive Diseases and Sciences·N YukiH Okayama
Jan 1, 1994·Archives of Virology·D TanM H Ng
May 1, 1995·Journal of General Internal Medicine·I ScotiniotisP F Malet
Mar 15, 2006·Digestive Diseases and Sciences·Dulciene Maria Magalhães QueirozHugo Tanno
Mar 20, 2004·Journal of Hepatology·Giovanna VonaValérie Thiers
May 6, 1997·Clinica Chimica Acta; International Journal of Clinical Chemistry·S YamadaH Kawasaki
Jan 1, 1996·Journal of Hepatology·J K DelladetsimaI Vafiadis
Apr 16, 2003·Health Policy·Isaac D MontoyaDonna D Whitsett
Mar 1, 1997·Research in Virology·F PiccininoE Sagnelli
Feb 13, 2001·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·A C HaushoferW M Halbmayer
Feb 26, 2000·International Journal of Dermatology·M D MignognaE Bucci
Aug 2, 2000·Journal of Gastroenterology and Hepatology·D Amarapurkar
May 21, 1992·The New England Journal of Medicine·G D KelenT C Quinn
Jun 5, 2008·Journal of Public Health Policy·Muhammad Naeem KhattakTariq Mahmood Roshan
Mar 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark S Sulkowski, David L Thomas
Oct 1, 1995·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·J M PawlotskyD Dhumeaux
Feb 7, 2009·European Journal of Public Health·Gaby SroczynskiUwe Siebert
Nov 1, 1996·Journal of Viral Hepatitis·Y YamakawaK Tanikawa
Mar 1, 1992·Journal of Gastroenterology and Hepatology·S D LeeK J Lo
Nov 1, 1992·Journal of Gastroenterology and Hepatology·N IshiguroH Obata
Mar 1, 1996·Journal of Gastroenterology and Hepatology·Y HigashiM Ando
Oct 1, 1995·Alcoholism, Clinical and Experimental Research·M E Coelho-LittleE R Schiff
Feb 7, 2001·Clinical Microbiology Reviews·N N Zein
Nov 1, 1993·Archives of Disease in Childhood·I al-Fawaz, S Ramia
Jan 1, 1993·Gut·H Schmilovitz-WeissG Dusheiko
Oct 1, 1995·Gut·J C BoothH C Thomas
May 20, 2005·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Uwe SiebertSiegbert Rossol
Oct 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B DussolY Berland
Nov 1, 1991·Journal of Hepatology·P J Scheuer
Apr 23, 2005·American Journal of Obstetrics and Gynecology·Beth A Plunkett, William A Grobman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.